Sign up United Kingdom
Proactive Investors - Run By Investors For Investors
Markets

PRE-MARKET MOVERS: Teva Pharmaceutical boosted as Buffett's Berkshire Hathaway buys in again; Verastem down

Retailer Macy's Inc and Micron Technology Inc are also in focus before the New York bell
1526471791_WarrenBuffet_353934110.jpg
Pictured is the Sage of Omaha, Warren Buffett

US futures are now pointing higher and before the bell, Israel-based pharma giant Teva Pharmaceutical  Industries Ltd (NASDAQ:TEVA) is up 4.68% to US$21.25.

It comes after a regulatory filing from Warren Buffett's Berkshire Hathaway (NYSE:BRK) revealed the latter had nearly doubled its stake in the company during the first quarter.

Berkshire has added 21.6mln more shares of Teva, bringing its entire stake to 40.54mln shares. It also boosted its stake in Apple (NASDAQ:AAPL) and agri-giant Monsanto Company (NYSE:MON).

Elsewhere, Macy's Inc (NYSE:M) shares are up 0.23% to US$30 ahead of the bell and ahead of quarterly earnings, in which analysts expect to see US$0.35 per share on revenue of US$5.39bn before the opening bell.

Micron Technology Inc (NASDAQ:MU) shares are up 1.5% to US$54.82 in pre-market deals after RBC Capital started the stock with an 'outperform' rating.

Yesterday, Stifel analyst Kevin Cassidy raised his price target on the stock to US$101 from US$95. The new target is reportedly the highest on Wall Street, and represents more than 90% upside from current levels.

Meanwhile, Verastem Inc (NASDAQ:VSTM) shares plunged 9.73% to US$4.73 before the bell. It came as the firm unveiled a US$35mln stock offering.

Arbor Realty Trust (NYSE:ABR), the real estate investor, saw shares plunge over 4% to US$8.93 after-hours after the mortgage lender also announced a public offering of shares.


No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use